CTEV (Claritev) Moat Score: 1/10 (As of Jun. 28, 2026)


CTEV Claritev Corp CTEV
56 GF Score
Price $33.15
GF Value $31.33
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Claritev Moat Score?

Claritev CTEV -4.52% 56 Moat Score is 1 as of Jun. 28, 2026. GuruFocus rates CTEV with a GF Score™ of 56/100 and a GF Value™ of $31.33 (Fairly Valued). The stock has 6 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Claritev ranks better than 74.89% on this metric.

Claritev has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

Claritev has No Moat: Claritev Corp lacks discernible competitive advantages such as market leadership, intellectual property, or significant customer switching costs. Its position in the market is not defensible.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Claritev might have No Moat - Very weak/transient advantages.

Claritev  (NYSE:CTEV) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Claritev Moat Score Related Terms

CTEV vs NRC, EVH, TBRG: Moat Score Comparison

For the Health Information Services subindustry, Claritev's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Claritev Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Claritev's Moat Score distribution charts can be found below:

* The bar in red indicates where Claritev's Moat Score falls into.


CTEV
56GF Score
Claritev Corp CTEV
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
Claritev (CTEV) has a Moat Score of 1 as of Jun. 28, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Claritev ranks #171 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 25.1%.
Is Claritev's Moat Score too high?
Claritev's current Moat Score is 1. Based on the distribution chart, Claritev ranks #171 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Claritev has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Claritev's Moat Score compare to NRC and EVH?
According to the Healthcare Providers & Services industry distribution chart, Claritev ranks #171 out of 681 companies for Moat Score. This puts Claritev in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Claritev's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Claritev stock overvalued right now?
Based on GuruFocus' analysis, Claritev (CTEV) is currently considered Fairly Valued. The stock's GF Value™ is $31.33, compared to a current price of $33.15 — trading 5.8% above its estimated fair value. The current Moat Score is 1. Claritev's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Claritev (CTEV), the current Moat Score is 1 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Claritev (CTEV) Overvalued in 2026?

Based on GuruFocus' analysis, Claritev stock appears to be overvalued. The current stock price of $33.15 is trading 5.8% above its estimated GF Value™ of $31.33. GuruFocus considers Claritev to be Fairly Valued.

Key valuation signals for CTEV:

  • Moat Score: 1
  • GF Value™: $31.33 vs. price of $33.15 (5.8% above fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the CTEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Claritev Business Description

Address 7900 Tysons One Place, Suite 400, McLean, VA, USA, 22102
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
56GF Score

Get the complete analysis for CTEV

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.15
Price
$31.33
GF Value